Publicacións (226) Publicacións nas que participase algún/ha investigador/a Ver datos de investigación referenciados.

filter_list Pediatrics

2025

  1. A 5-transcript signature for discriminating viral and bacterial etiology in pediatric pneumonia

    iScience, Vol. 28, Núm. 2

  2. A Phase 3B, Open-Label Study to Evaluate the Immunogenicity and Safety of the Quadrivalent Meningococcal Nimenrix® Vaccine When Given to Healthy Infants at 3 and 12 Months of Age

    Infectious Diseases and Therapy, Vol. 14, Núm. 2, pp. 463-481

  3. Safety, tolerability, and immunogenicity of pentavalent meningococcal MenABCWY vaccine in healthy infants: A phase 2b randomized clinical trial

    Human vaccines & immunotherapeutics, Vol. 21, Núm. 1, pp. 2463194

2024

  1. A phase 4, open-label study to evaluate the safety and immunogenicity of DTaP5-HBV-IPV-Hib in children previously vaccinated with DTaP2-HBV-IPV-Hib or DTaP5-HBV-IPV-Hib (V419-016)

    Human Vaccines and Immunotherapeutics, Vol. 20, Núm. 1

  2. Clinical-Hematological Changes and Predictors of Severity in Acute Food Protein–Induced Enterocolitis Syndrome Reactions at Oral Food Challenge: A Multicenter Observational Study

    Journal of Allergy and Clinical Immunology: In Practice, Vol. 12, Núm. 9, pp. 2454-2467.e8

  3. Disparate kinetics in immune response of two different Haemophilus influenzae type b conjugate vaccines: Immunogenicity and safety observations from a randomized controlled phase IV study in healthy infants and toddlers using a 2+1 schedule

    Human Vaccines and Immunotherapeutics, Vol. 20, Núm. 1

  4. External Validation of the Discriminative Validity of the ReSVinet Score and Development of Simplified ReSVinet Scores in Secondary Care

    The Journal of infectious diseases, Vol. 229, Núm. 1, pp. S18-S24

  5. External validation of a multivariable prediction model for identification of pneumonia and other serious bacterial infections in febrile immunocompromised children

    Archives of Disease in Childhood, Vol. 109, Núm. 1, pp. 58-66

  6. Host gene expression signatures to identify infection type and organ dysfunction in children evaluated for sepsis: a multicentre cohort study

    The Lancet Child and Adolescent Health, Vol. 8, Núm. 5, pp. 325-338

  7. Integration and validation of host transcript signatures, including a novel 3-transcript tuberculosis signature, to enable one-step multiclass diagnosis of childhood febrile disease

    Journal of Translational Medicine, Vol. 22, Núm. 1

  8. Plasma Protein Biomarkers Distinguish Multisystem Inflammatory Syndrome in Children From Other Pediatric Infectious and Inflammatory Diseases

    The Pediatric infectious disease journal, Vol. 43, Núm. 5, pp. 444-453

  9. Raising AWaRe-ness of Antimicrobial Stewardship Challenges in Pediatric Emergency Care: Results from the PERFORM Study Assessing Consistency and Appropriateness of Antibiotic Prescribing Across Europe

    Clinical Infectious Diseases, Vol. 78, Núm. 3, pp. 526-534

  10. Safety and Immunogenicity of a ChAd155-Vectored Respiratory Syncytial Virus Vaccine in Infants 6-7 Months of age: A Phase 1/2 Randomized Trial

    The Journal of infectious diseases, Vol. 229, Núm. 1, pp. 95-107

  11. Short- and mid-term morbidity and primary-care burden due to infant respiratory syncytial virus infection: A Spanish 6-year population-based longitudinal study

    Pediatric Allergy and Immunology, Vol. 35, Núm. 5

  12. Substantial Burden of Nonmedically Attended RSV Infection in Healthy-Term Infants: An International Prospective Birth Cohort Study

    Journal of Infectious Diseases

  13. The value of white blood cell count in predicting serious bacterial infections in children presenting to the emergency department: a multicentre observational study

    Archives of Disease in Childhood

  14. Which low urgent triaged febrile children are suitable for a fast track? An observational European study

    Emergency Medicine Journal, Vol. 41, Núm. 4, pp. 236-241

2023

  1. A Phase III, multicenter, randomized, double-blind, active comparator-controlled study to evaluate the safety, tolerability, and immunogenicity of V114 compared with PCV13 in healthy infants (PNEU-PED-EU-1)

    Vaccine, Vol. 41, Núm. 21, pp. 3387-3398

  2. Are children with prolonged fever at a higher risk for serious illness? A prospective observational study

    Archives of Disease in Childhood, Vol. 108, Núm. 8, pp. 632-639

  3. Biobanking and consenting to research: a qualitative thematic analysis of young people’s perspectives in the North East of England

    BMC Medical Ethics, Vol. 24, Núm. 1